(ZLCS:Consolidated Issue listed on NASDAQ Capital Market)
John Richard Kirwan BSc, FRCP, M.D.
Member of Clinical Advisor for Immuno Inflammatory, Zalicus Inc.
|Age||Total Calculated Compensation||This person is connected to 38 board members in 2 different organizations across 2 different industries.|
See Board Relationships
John Richard Kirwan, BSc, FRCP, M.D. serves as a Consultant Rheumatologist and Professor of Rheumatic Diseases at the University of Bristol, England. Dr. Kirwan coordinated the team that first showed unequivocally that glucocorticoids are able to hinder the progress of rheumatoid arthritis. Dr. Kirwan serves as Head of the Academic Unit in Bristol, where his research interests continue to centre on glucocorticoids and relate to new types of glucocorticoid treatment and ...
245 First StreetPhone: 617-301-7000
Cambridge, Massachusetts 02142
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|